#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	10278	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2177	461.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1422	1422	C	585	C	573	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	19220	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3532	532.6	0	.	n	.	0	T695C	SNP	695	695	T	1032	1032	C	574	C	557	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	19220	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3532	532.6	0	.	n	.	0	G1337A	SNP	1337	1337	G	1674	1674	A	607	A	591	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	19220	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3532	532.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2308	2308	C	576	C,T	430,112	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	19220	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3532	532.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2382	2382	A	574	A	552	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	19220	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3532	532.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	2934	2934	C	596	C,A,G	572,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1064	folP	858	858	91.61	folP.l15.c4.ctg.1	1466	71.1	0	.	p	.	0	V36A	NONSYN	106	108	GTG	401	403	GCG	118;118;121	G;C;G	113;113;115	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1064	folP	858	858	91.61	folP.l15.c4.ctg.1	1466	71.1	0	.	p	.	0	Q50R	NONSYN	148	150	CAG	443	445	CGG	107;108;107	C;G;G	105;104;103	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1064	folP	858	858	91.61	folP.l15.c4.ctg.1	1466	71.1	0	.	p	.	0	S68L	NONSYN	202	204	TCG	497	499	TTG	88;87;86	T;T;G	82;85;83	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1064	folP	858	858	91.61	folP.l15.c4.ctg.1	1466	71.1	0	.	p	.	0	A90V	NONSYN	268	270	GCG	563	565	GTT	74;74;76	G;T;T	73;71;75	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1064	folP	858	858	91.61	folP.l15.c4.ctg.1	1466	71.1	0	.	p	.	0	I105V	NONSYN	313	315	ATT	608	610	GTT	99;98;97	G;T;T	94;91;94	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1064	folP	858	858	91.61	folP.l15.c4.ctg.1	1466	71.1	0	.	p	.	0	N125T	NONSYN	373	375	AAT	668	670	ACC	101;101;99	A;C;C	98;98;98	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1064	folP	858	858	91.61	folP.l15.c4.ctg.1	1466	71.1	0	.	p	.	0	R135C	NONSYN	403	405	CGT	698	700	TGT	103;102;101	T,C;G;T,C	91,1;97;94,1	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1064	folP	858	858	91.61	folP.l15.c4.ctg.1	1466	71.1	0	.	p	.	0	K151E	NONSYN	451	453	AAA	746	748	GAA	91;90;90	G;A;A	89;88;88	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1064	folP	858	858	91.61	folP.l15.c4.ctg.1	1466	71.1	0	.	p	.	0	T152N	NONSYN	454	456	ACC	749	751	AAC	90;91;91	A;A,C;C	89;87,1;89	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1064	folP	858	858	91.61	folP.l15.c4.ctg.1	1466	71.1	0	.	p	.	0	A172T	NONSYN	514	516	GCG	809	811	ACA	85;87;86	A;C;A	82;85;82	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1064	folP	858	858	91.61	folP.l15.c4.ctg.1	1466	71.1	0	.	p	.	0	A175E	NONSYN	523	525	GCG	818	820	GAA	86;87;88	G;A;A	85;86;86	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1064	folP	858	858	91.61	folP.l15.c4.ctg.1	1466	71.1	0	.	p	.	0	E176T	NONSYN	526	528	GAA	821	823	ACC	92;93;92	A;C;C	89;92;91	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1064	folP	858	858	91.61	folP.l15.c4.ctg.1	1466	71.1	0	.	p	.	0	I178V	NONSYN	532	534	ATC	827	829	GTC	94;94;95	G;T;C	92;92;93	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1064	folP	858	858	91.61	folP.l15.c4.ctg.1	1466	71.1	0	.	p	.	0	I188T	NONSYN	562	564	ATA	857	859	ACG	104;103;104	A,T;C;G	100,1;101;98	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1064	folP	858	858	91.61	folP.l15.c4.ctg.1	1466	71.1	0	.	p	.	0	P200N	NONSYN	598	600	CCC	893	895	AAC	108;108;108	A;A;C	105;103;104	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1064	folP	858	858	91.61	folP.l15.c4.ctg.1	1466	71.1	0	.	p	.	0	F220L	NONSYN	658	660	TTT	953	955	TTG	125;127;127	T;T;G	120;122;119	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1064	folP	858	858	91.61	folP.l15.c4.ctg.1	1466	71.1	0	.	p	.	0	A239T	NONSYN	715	717	GCA	1010	1012	ACC	110;110;111	A;C;C	108;107;109	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1064	folP	858	858	91.61	folP.l15.c4.ctg.1	1466	71.1	0	.	p	.	0	N240D	NONSYN	718	720	AAT	1013	1015	GAC	111;110;109	G;A;C	108;106;107	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1064	folP	858	858	91.61	folP.l15.c4.ctg.1	1466	71.1	0	.	p	.	0	E243A	NONSYN	727	729	GAA	1022	1024	GCG	106;103;104	G;C;G	105;74;102	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1064	folP	858	858	91.61	folP.l15.c4.ctg.1	1466	71.1	0	.	p	.	0	S255A	NONSYN	763	765	TCC	1058	1060	GCT	97;97;96	G;C,G;T	95;92,1;88	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1064	folP	858	858	91.61	folP.l15.c4.ctg.1	1466	71.1	1	SNP	p	R230S	1	.	.	688	690	AGC	983	985	AGC	124;125;126	A;G;C	122;124;123	folP.Neisseria_meningitidis_MC58_v2_01707:1:1:R230S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	3418	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3442	97.8	1	SNP	p	S91F	0	.	.	271	273	TCC	588	590	TCC	102;102;102	T;C;C	98;98;96	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	3418	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3442	97.8	1	SNP	p	D95N	0	.	.	283	285	GAC	600	602	GAC	99;97;98	G,A;A;C	90,1;88;91	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	3418	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3442	97.8	1	SNP	p	D95G	0	.	.	283	285	GAC	600	602	GAC	99;97;98	G,A;A;C	90,1;88;91	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_L_00489c	mtrR.WHO_L_00489c	1	1	27	1076	mtrR	633	633	100.0	mtrR.l6.c4.ctg.1	1312	80.0	1	SNP	p	G45D	1	.	.	133	135	GAC	467	469	GAC	130;131;131	G;A,G;C	126;124,1;125	mtrR.WHO_L_00489c:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	598	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c30.ctg.1	1152	50.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	3148	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3076	100.0	1	SNP	p	D86N	0	.	.	256	258	GAC	704	706	GAC	140;141;142	G;A;C	137;139;138	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	3148	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3076	100.0	1	SNP	p	S87I	0	.	.	259	261	AGT	707	709	AGT	141;140;141	A;G;T	138;138;137	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	3148	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3076	100.0	1	SNP	p	S87R	0	.	.	259	261	AGT	707	709	AGT	141;140;141	A;G;T	138;138;137	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	3148	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3076	100.0	1	SNP	p	S87W	0	.	.	259	261	AGT	707	709	AGT	141;140;141	A;G;T	138;138;137	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	3148	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3076	100.0	1	SNP	p	S88P	0	.	.	262	264	TCC	710	712	TCC	141;143;143	T;C;C	137;140;141	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	2664	parE	1986	1986	100.0	parE.l6.c4.ctg.1	2567	101.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1478	1480	GGC	134;132;131	G;G;C	131;128;128	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	2596	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2441	104.5	1	SNP	p	A311V	0	.	.	931	933	GCC	1304	1306	GCC	141;141;141	G;C;C	136;136;136	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2596	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2441	104.5	1	SNP	p	I312M	1	.	.	934	936	ATG	1307	1309	ATG	143;143;144	A;T;G	139;138;140	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2596	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2441	104.5	1	SNP	p	T316P	0	.	.	946	948	ACC	1319	1321	ACC	149;147;145	A;C;C	142;140;138	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2596	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2441	104.5	1	SNP	p	V316T	1	.	.	946	948	ACC	1319	1321	ACC	149;147;145	A;C;C	142;140;138	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2596	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2441	104.5	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1820	1822	ACC	133;133;135	A;C;C	122;127;127	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2596	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2441	104.5	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1874	1876	GCG	122;121;120	G;C;G	117;116;117	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2596	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2441	104.5	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1874	1876	GCG	122;121;120	G;C;G	117;116;117	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2596	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2441	104.5	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1997	1999	GGT	98;96;94	G;G;T	94;91;90	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2596	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2441	104.5	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2006	2008	AGC	87;86;84	A;G;C	83;84;81	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2596	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2441	104.5	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2024	2026	CCG	61;59;60	C,G;C,G;G	53,4;50,2;49	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	3742	ponA	2397	2397	99.96	ponA.l6.c17.ctg.1	3063	119.7	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1604	1606	CTG	144;143;145	C,G;T;G	134,1;133;139	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1450	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1791	79.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	603	603	C	87	C	81	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	222	porB1a	984	292	90.54	porB1a.l6.c30.ctg.2	378	20.6	0	.	p	.	0	H217N	NONSYN	649	651	CAT	111	113	AAT	11;11;10	A;A;T	11;11;10	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	222	porB1a	984	292	90.54	porB1a.l6.c30.ctg.2	378	20.6	0	.	p	.	0	D218N	NONSYN	652	654	GAT	114	116	AAT	10;10;10	A;A;T	10;10;10	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	222	porB1a	984	292	90.54	porB1a.l6.c30.ctg.2	378	20.6	0	.	p	.	0	V226A	NONSYN	676	678	GTA	138	140	GCA	12;12;12	G;C;A	12;12;12	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	222	porB1a	984	292	90.54	porB1a.l6.c30.ctg.2	378	20.6	0	.	p	.	0	.	MULTIPLE	700	702	ACT	161	163	GTA	11;11;11	G;T;A	11;10;10	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	222	porB1a	984	292	90.54	porB1a.l6.c30.ctg.2	378	20.6	0	.	p	.	0	S236N	NONSYN	706	708	AGC	167	169	AAC	11;11;12	A;A,G;C	10;10,1;11	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	222	porB1a	984	292	90.54	porB1a.l6.c30.ctg.2	378	20.6	0	.	p	.	0	N237M	NONSYN	709	711	AAC	170	172	ATG	12;12;12	A;T,A;G	11;11,1;11	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	222	porB1a	984	292	90.54	porB1a.l6.c30.ctg.2	378	20.6	0	.	p	.	0	D238fs	FSHIFT	712	712	G	173	173	G	15	G	13	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	1890	porB1b	1035	1035	98.76	porB1b.l6.c4.ctg.1	1673	111.5	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	947	947	T	152	T	146	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	1890	porB1b	1035	1035	98.76	porB1b.l6.c4.ctg.1	1673	111.5	1	SNP	p	G120K	0	.	.	358	360	GGT	674	676	GGT	132;126;126	G,C;G;T	127,1;122;117	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	1890	porB1b	1035	1035	98.76	porB1b.l6.c4.ctg.1	1673	111.5	1	SNP	p	A121D	0	.	.	361	363	GCC	677	679	GCC	124;123;123	G;C;C	119;120;121	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	1890	porB1b	1035	1035	98.76	porB1b.l6.c4.ctg.1	1673	111.5	1	SNP	p	A121N	0	.	.	361	363	GCC	677	679	GCC	124;123;123	G;C;C	119;120;121	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	6666	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4983	130.8	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2132	2134	CAT	149;148;147	C,A;A;T	143,1;144;142	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	820	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1125	71.7	1	SNP	p	V57M	1	.	.	169	171	ATG	543	545	ATG	173;174;172	A;T;G,T	168;167;164,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
